Senescent cells promote NAD tissue decline during aging through CD38 enzymes which can now become a novel therapeutic target. Nicotinamide …
Continue reading “NAD boosting to reverse senescence and inflammaging”
Avenna claims the first reliable, quantitative biomarkers for subclinical systemic chronic inflammation. Using the science of glycomics, British start-up Avenna …
Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging. …
Continue reading “Targeting inflammaging: the hidden “inflammapath” inside us”
Neurodegenerative disease is associated with age-related chronic, low grade inflammation, but studies suggest that this could be reversed with over …
Continue reading “Inflammaging – could ibuprofen be the answer?”
One of the largest deals in Irish biotech history sees Roche gain rights to full Inflazome portfolio. The Swiss company …
Continue reading “Inflammaging biotech acquired by Roche for €380m”
Researchers use metformin to repair broken cell machinery and drastically lower dangerous inflammation. Inflammaging is one of the latest Longevity …
Continue reading “Metformin boost for inflammaging research”
Waste not, want not – faecal microbiome experiment could lead to novel antiaging therapies. Faeces might not spring straight into …
Continue reading “Faecal transplants shown to reverse hallmarks of aging”
GlycanAge – unlock healthy aging through a test that accurately measures your unique response to lifestyle change. Over the next …
Continue reading “GlycanAge – deploying precision health strategies to maximise healthspan”
Longevity is a growing space, with $2 billion invested in longevity businesses in 2021 alone. The industry’s focus is not …
Continue reading “How to live longer: what is longevity and how can you improve it?”
